6564 Results

People

  1. Gonen
    Gonen
  2. Panageas
    Panageas
  3. Patil
    Patil
  4. Giralt
    Giralt
  5. Zhang
    Zhang
  6. Heller
    Heller
  7. Devlin
    Devlin
  8. Seshan
    Seshan
  9. Jarnagin
    Jarnagin
  10. D'Angelica
    D'Angelica

Groups

  1. Biostatistics Service (6564)
  2. Epidemiology and Biostatistics (6564)
  3. Department of Medicine (3848)
  4. Solid Tumor Oncology Division (2571)
  5. Survivorship Research (2487)
  6. Surgery (2392)
  7. Population Sciences Research Program (2339)
  8. Center for Pancreatic Cancer Research (2080)
  9. GSK Faculty (1977)
  10. Department of Pathology and Laboratory Medicine (1573)
  1. "Biostatistics Service"
Formats
  1. Journal Article (3978)
  2. Meeting Abstract (2394)
  3. Research Letter (51)
  4. Conference Paper (37)
  5. Correspondence (26)
  6. Editorial (25)
  7. Review (21)
  8. Miscellaneous (14)
  9. Book Section (13)
  10. Book Whole (3)
  11. Guidelines (2)
Groups
  1. Biostatistics Service (6564)
  2. Epidemiology and Biostatistics (6564)
  3. Department of Medicine (3848)
  4. Solid Tumor Oncology Division (2571)
  5. Survivorship Research (2487)
  6. Surgery (2392)

More Groups

People
  1. Mithat Gonen (1028)
  2. Sean Devlin (601)
  3. Katherine Panageas (512)
  4. Sujata Patil (511)
  5. Sergio Giralt (464)
  6. Zhigang Zhang (427)

More People

Years
  1. 2025 (118)
  2. 2024 (362)
  3. 2023 (411)
  4. 2022 (407)
  5. 2021 (369)
  6. 2020 (394)

More Years

Publications
  1. Journal of Clinical Oncology (1058)
  2. Blood (432)
  3. Annals of Surgical Oncology (308)
  4. International Journal of Radiation Oncology, Biology, Physics (233)
  5. Clinical Cancer Research (195)
  6. Biology of Blood and Marrow Transplantation (174)

More Publications

Publishers
  1. American Society of Clinical Oncology (1124)
  2. Elsevier Inc. (930)
  3. Springer (625)
  4. American Society of Hematology (486)
  5. American Association for Cancer Research (430)
  6. Nature Publishing Group (311)

More Publishers

Results (6564)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Bronchial or pulmonary artery chemoembolization for unresectable and unablatable lung metastases: A phase I clinical trial
    Journal Article

    Boas, F. E.; Kemeny, N. E.; Sofocleous, C. T.; Yeh, R.; Thompson, V. R.; Hsu, M.; Moskowitz, C. S.; Ziv, E.; Yarmohammadi, H.; Bendet, A.; more...
    Radiology (2021)

    Fulltext@MSK | Save
  • Translational strategies for repotrectinib in neuroblastoma
    Journal Article

    O'Donohue, T. J.; Ibáñez, G.; Coutinho, D. F.; Mauguen, A.; Siddiquee, A.; Rosales, N.; Calder, P.; Ndengu, A.; You, D.; Long, M.; more...
    Molecular Cancer Therapeutics (2021)

    Fulltext@MSK | Save
  • Zanubrutinib, obinutuzumab, and venetoclax with minimal residual disease-driven discontinuation in previously untreated patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: A multicentre, single-arm, phase 2 trial
    Journal Article

    Soumerai, J. D.; Mato, A. R.; Dogan, A.; Seshan, V. E.; Joffe, E.; Flaherty, K.; Carter, J.; Hochberg, E.; Barnes, J. A.; Hamilton, A. M.; more...
    The Lancet Haematology (2021)

    Fulltext@MSK | Save
  • Impact of telemedicine on patient satisfaction and perceptions of care quality in radiation oncology
    Journal Article

    Shaverdian, N.; Gillespie, E. F.; Cha, E.; Kim, S. Y.; Benvengo, S.; Chino, F.; Kang, J. J.; Li, Y.; Atkinson, T. M.; Lee, N.; more...
    Journal of the National Comprehensive Cancer Network (2021)

    Fulltext@MSK | Save
  • Risks and benefits of reinduction ipilimumab/nivolumab in melanoma patients previously treated with ipilimumab/nivolumab
    Journal Article

    Chapman, P. B.; Jayaprakasam, V. S.; Panageas, K. S.; Callahan, M.; Postow, M. A.; Shoushtari, A. N.; Wolchok, J. D.; Betof Warner, A.
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Randomized phase 2 trial of abiraterone acetate plus prednisone, degarelix, or the combination in men with biochemically recurrent prostate cancer after radical prostatectomy
    Journal Article

    Autio, K. A.; Antonarakis, E. S.; Mayer, T. M.; Shevrin, D. H.; Stein, M. N.; Vaishampayan, U. N.; Morris, M. J.; Slovin, S. F.; Heath, E. I.; Tagawa, S. T.; more...
    European Urology Open Science (2021)

    Fulltext@MSK | Save
  • Controlled backfill in oncology dose-finding trials
    Journal Article

    Dehbi, H. M.; O'Quigley, J.; Iasonos, A.
    Contemporary Clinical Trials (2021)

    Fulltext@MSK | Save
  • Association of melanoma-risk variants with primary melanoma tumor prognostic characteristics and melanoma-specific survival in the GEM study
    Journal Article

    Davari, D. R.; Orlow, I.; Kanetsky, P. A.; Luo, L.; Busam, K. J.; Sharma, A.; Kricker, A.; Cust, A. E.; Anton-Culver, H.; Gruber, S. B.; more...
    Current Oncology (2021)

    Fulltext@MSK | Save
  • Genome-derived classification signature for ampullary adenocarcinoma to improve clinical cancer care
    Journal Article

    Chakraborty, S.; Ecker, B. L.; Seier, K.; Aveson, V. G.; Balachandran, V. P.; Drebin, J. A.; D'Angelica, M. I.; Kingham, T. P.; Sigel, C. S.; Soares, K. C.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Excellent response to very-low-dose radiation (4 Gy) for indolent B-cell lymphomas: Is 4 Gy suitable for curable patients?
    Journal Article

    Imber, B. S.; Chau, K. W.; Lee, J.; Lee, J.; Casey, D. L.; Yang, J. C.; Wijentunga, N. A.; Shepherd, A.; Hajj, C.; Qi, S.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save